A Phase 3 Study Evaluating Continuation, Tapering, and...

  • Main
  • 2017 / 06
  • A Phase 3 Study Evaluating Continuation, Tapering, and...

A Phase 3 Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol after 1 Year of Therapy in Early Rheumatoid Arthritis Patients

Weinblatt, Michael E., Bingham, Clifton O., Burmester, Gerd-Rüdiger, Bykerk, Vivian P., Furst, Daniel E., Mariette, Xavier, van der Heijde, Désirée, van Vollenhoven, Ronald, Van Lunen, Brenda, Ecoffet
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.40196
Date:
June, 2017
File:
PDF, 1.07 MB
english, 2017
Conversion to is in progress
Conversion to is failed